| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.03. | ANAGENICS LIMITED: Appendix 3X MR JOSHUA GORDON | - | ASX | ||
| 01.03. | ANAGENICS LIMITED: AN1 - Director Appointment | - | ASX | ||
| ANAGENICS Aktie jetzt für 0€ handeln | |||||
| 27.02. | ANAGENICS LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
| 25.02. | ANAGENICS LIMITED: AN1 - 1H FY26 Presentation | 1 | ASX | ||
| 24.02. | ANAGENICS LIMITED: Anagenics - 1H FY26 Result Highlights | - | ASX | ||
| 24.02. | ANAGENICS LIMITED: Anagenics - 1H26 HY Report DEC 2025 | - | ASX | ||
| 24.02. | ANAGENICS LIMITED: Appendix 4D 1H FY26 DEC 2025 | - | ASX | ||
| 12.02. | ANAGENICS LIMITED: Becoming a substantial holder | - | ASX | ||
| 12.02. | ANAGENICS LIMITED: Becoming a substantial holder | - | ASX | ||
| 12.02. | ANAGENICS LIMITED: Notification regarding unquoted securities - AN1 | 1 | ASX | ||
| 09.02. | ANAGENICS LIMITED: Ceasing to be a substantial holder from FOS | 1 | ASX | ||
| 09.02. | ANAGENICS LIMITED: Change in substantial holding from HNG | 1 | ASX | ||
| 08.02. | ANAGENICS LIMITED: Application for quotation of securities - AN1 | - | ASX | ||
| 29.01. | ANAGENICS LIMITED: Notification of cessation of securities - AN1 | 1 | ASX | ||
| 29.01. | ANAGENICS LIMITED: Notification of cessation of securities - AN1 | 1 | ASX | ||
| 29.01. | ANAGENICS LIMITED: Appendix 4C & Activity Report for Q2 FY2026 | 5 | ASX | ||
| 29.01. | ANAGENICS LIMITED: Results of Meeting | - | ASX | ||
| 29.01. | ANAGENICS LIMITED: Change of Address | - | ASX | ||
| 05.01. | ANAGENICS LIMITED: Change in substantial holding from FOS | - | ASX | ||
| 05.01. | ANAGENICS LIMITED: Change in substantial holding from HNG | 1 | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 34,495 | -0,06 % | Novo Nordisk: Wegovy erhält EU-Zulassung für Lieferung ohne Kühlkette | Die Europäische Arzneimittelagentur EMA hat eine Aktualisierung der Produktinformation für Wegovy zugelassen, die es erlaubt, das Präparat bei der Auslieferung an Patienten bis zu 48 Stunden bei Temperaturen... ► Artikel lesen | |
| AURORA CANNABIS | 3,150 | +0,32 % | Aurora & Co. vor Höllenritt: Tilray schon durch, aber Berichtssaison könnte Cannabis-Aktien beben lassen | © Foto: adobe.stock.comDie Quartalsberichtssaison läuft an. Noch plätschert sie vergleichsweise gemächlich dahin. Zunächst stehen die US-Banken im Fokus. Doch in wenigen Tagen wird es auch im Cannabis-Sektor... ► Artikel lesen | |
| CANOPY GROWTH | 0,978 | -0,12 % | CANOPY GROWTH CORPORATION: Stabilität als Signal | ||
| TILRAY BRANDS | 5,920 | +0,34 % | Tilray Brands Inc (2): Tilray files for U.S. ATM equity sale of up to $180M | ||
| VERTEX PHARMACEUTICALS | 374,40 | +0,01 % | If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| CRONOS GROUP | 2,254 | -2,42 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Announces Resignation of Director | Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,296 | +0,31 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 5,740 | -4,01 % | Green Thumb Industries Inc: Green Thumb releases social impact report | ||
| IONIS PHARMACEUTICALS | 65,56 | +0,71 % | Ionis exec shares method to the Madness after 2026 Drug Name Tournament win | ||
| NOVERIS HEALTH SCIENCES | 1,170 | 0,00 % | XFRA 0NF1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNOVERIS HEALTH SCI.... ► Artikel lesen | |
| WAYLAND GROUP | - | - | EQS-News: Berger Montague (Canada) PC: Ankündigung der Anhörung zur Genehmigung des Vergleichs - Wayland Group Corp., Scott Langille, Gerhard Müller, Paul Pathak, Eric Silver, M. Stein, John Does 1-3, Canaccord Genuity Corp. und RF Securities Clearing LP | EQS-News: Berger Montague (Canada) PC
/ Schlagwort(e): Rechtssache/Sonstiges
ANKÜNDIGUNG DER ANHÖRUNG ZUR GENEHMIGUNG DES VERGLEICHS - KURZFASSUNG - WAYLAND... ► Artikel lesen | |
| SANTHERA PHARMACEUTICALS | 19,680 | -0,30 % | Santhera Pharmaceuticals Holding AG: Full Year 2025 Trading Update | Ad hoc announcement pursuant to Art. 53 LR
AGAMREE continues to build strong commercial momentum, delivering 98% revenue growth
Pratteln, Switzerland, March 12, 2026 - Santhera Pharmaceuticals... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 70,96 | +0,62 % | Nektar Therapeutics: Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting | Rezpegaldesleukin demonstrates statistically significant improvement in mean percent EASI improvement across both moderate and severe atopic dermatitis patients
Rezpegaldesleukin... ► Artikel lesen |